TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioCare Svenska AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
963
|
1,892
|
1,818 |
| Financial expenses |
16
|
18
|
16 |
| Earnings before taxes |
-53
|
46
|
118 |
| EBITDA |
-37
|
64
|
138 |
| Total assets |
748
|
451
|
732 |
| Current assets |
747
|
449
|
729 |
| Current liabilities |
168
|
211
|
425 |
| Equity capital |
11
|
66
|
24 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
4
|
4
|
6 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
1.5%
|
14.6%
|
3.3% |
| Turnover per employee |
241
|
473
|
303 |
| Profit as a percentage of turnover |
-5.5%
|
2.4%
|
6.5% |
| Return on assets (ROA) |
-4.9%
|
14.2%
|
18.3% |
| Current ratio |
444.6%
|
212.8%
|
171.5% |
| Return on equity (ROE) |
-481.8%
|
69.7%
|
491.7% |
| Change turnover |
-865
|
70
|
820 |
| Change turnover % |
-47%
|
4%
|
82% |
| Chg. No. of employees |
0
|
-2
|
-1 |
| Chg. No. of employees % |
0%
|
-33%
|
-14% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.